logo
Get Email Updates

Resources for Parents

From questions to confidence, it all starts here

Whether you’re expecting and exploring your options, planning your baby’s next well-visit, or just want to learn more, you’ve come to the right place. This resources page has helpful videos, guides, and tools to support you through RSV season.

Beyfortus basics to keep on hand

Our parent brochure is a handy reference when you’re learning about RSV and how Beyfortus can help protect your baby from serious RSV lung infection. It explains how Beyfortus works and includes important RSV facts and key safety info. All in a short, easy-to-read PDF you can save or share.

Be ready for the RSV talk

Whether you’re home with your baby or still awaiting their arrival, it helps to feel prepared for your next doctor’s visit. We’ve created these doctor discussion guides that match where you are in your journey, so you can feel confident knowing what to ask about RSV protection. Just choose the option that fits you best.

Download your discussion guide

Pick the guide that matches where you are in your journey, then download to print or save to your phone to take with you to your next appointment.

Parent-to-be guide PDF

New parent guide PDF

Video hub

Our video hub brings together stories from real moms, RSV guidance, and helpful info for the early months of parenthood. Whether you’re looking for reassurance or just want to know what to expect this RSV season, the video hub has something for you.

Watch Charzell’s story and see how RSV affected her family.

“I hope that learning how RSV affected my family will help another family avoid what we went through.”

Charzell—mom of Aiden and Ayani

Read about Charzell’s RSV experience

CHARZELL: I'd say, we're the typical family. We have two kids: Aiden, who just turned three, and Ayani, who's one.


I hope that learning how RSV affected my family will help another family avoid what we went through.


My husband and I both work full-time while the kids are in daycare. After daycare, we do homework, we eat dinner, we shower, get ready for bed. And we do it all over again the next day.


When I found out I was pregnant with Ayani, I did feel like I had it together. But that was until she was born. Ayani was born prematurely at 29 weeks and four days. She was born in April, but she stayed in the hospital until her due date, which was in July.


The day Ayani was discharged from the hospital, it was probably the best day of my life. We finally felt like a complete family and that nothing could go wrong.


Even though Ayani was born prematurely, at every checkup she was doing good and healthy.


A couple months after Ayani's hospital release, we traveled to Ohio to visit family. My nieces and nephews were there and one of them had a little cough. Although you wouldn't have thought much about the cough, we tried to keep them apart since Ayani was so small, but that didn't work.


A few days later I was out running errands and my mom called me in a panic. She said Ayani was choking on her spit, and it was just really big globs of mucus and that we needed to get her to the hospital.


I had raced back to my mom's house and once I got there I started crying. Ayani had already been through so much in her life, I didn't want anything to happen to her. I just wanted her to be okay.


When we got to the hospital, they suctioned out her nose and said her oxygen levels were fine, so they sent us home.


Once we got home, things did not get better. By the fourth day, she could not sleep. She'd sleep for maybe an hour, wake up and just cry.


On the second visit at the hospital, she was then diagnosed with RSV.


After she was diagnosed with RSV, we were sent home and told to just keep using the humidifier. My husband was back home and I just remember calling him and crying because I was just so scared.


It took more than a week, a very stressful week, before Ayani started to turn the corner.


I really wish we would've been given the option to protect Ayani against RSV. I absolutely would've done it. I'm just really glad that other parents have that opportunity.


IMPORTANT SAFETY INFORMATION

Your child should not take Beyfortus if your child has a history of serious allergic reactions to nirsevimab-alip or any of the ingredients in Beyfortus.


Before your child receives Beyfortus, tell your healthcare provider about all of your child's medical conditions, including if your child:

  • has ever had a reaction to Beyfortus.
  • has bleeding or bruising problems. If your child has a problem with bleeding or bruises easily, an injection could cause a problem.

Tell your healthcare provider about all the medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your infant should not receive a medicine called palivizumab if they have already received Beyfortus in the same RSV season.

Serious allergic reactions have happened with Beyfortus. Get medical help right away if your child has any of the following signs or symptoms of a serious allergic reaction:

  • swelling of the face, mouth, or tongue
  • difficulty swallowing or breathing
  • unresponsiveness
  • bluish color of skin, lips, or under fingernails
  • muscle weakness
  • severe rash, hives, or itching


The most common side effects of Beyfortus include rash and pain, swelling, or hardness at the site of your child's injection. These are not all the possible side effects of Beyfortus. Call your healthcare provider if you have questions about side effects.


INDICATION

Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:

  • Newborns and babies under l year of age born during or entering their first RSV season.
  • Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.


Please see full Prescribing Information including the patient information at the top of this site.

Video library

Additional resources

Frequently asked questions

Got questions? You’re not the only one. Visit our FAQs page to find quick answers to the questions parents ask most about RSV and Beyfortus.


IMPORTANT SAFETY INFORMATION
IMPORTANT SAFETY INFORMATION
INDICATION
IMPORTANT SAFETY INFORMATION

Your child should not take Beyfortus if your child has a history of serious allergic reactions to nirsevimab-alip or any of the ingredients in Beyfortus.

Before your child receives Beyfortus, tell your healthcare provider about all of your child’s medical conditions, including if your child:

  • has ever had a reaction to Beyfortus.

  • has bleeding or bruising problems. If your child has a problem with bleeding or bruises easily, an injection could cause a problem.


Tell your healthcare provider about all the medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your infant should not receive a medicine called palivizumab if they have already received Beyfortus in the same RSV season.

Serious allergic reactions have happened with Beyfortus. Get medical help right away if your child has any of the following signs or symptoms of a serious allergic reaction:

  • swelling of the face, mouth, or tongue

  • difficulty swallowing or breathing

  • unresponsiveness

  • bluish color of skin, lips, or under fingernails

  • muscle weakness

  • severe rash, hives, or itching


The most common side effects of Beyfortus include rash and pain, swelling, or hardness at the site of your child’s injection. These are not all the possible side effects of Beyfortus. Call your healthcare provider if you have questions about side effects.

Please see full Prescribing Information, including Patient Information, for more details.

Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.

INDICATION

Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:

  • Newborns and babies under 1 year of age born during or entering their first RSV season.

  • Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.
MAT-US-2510101-v1.0-09/2025